[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"condbio:essential-thrombocythemia:calr-gene":3},{"condition":4,"biomarker":5,"total":6,"trials":7},"Essential Thrombocythemia","CALR Gene",4,[8,16,22,28],{"nct_id":9,"title":10,"phases":11,"status":13,"updated_at":14,"content_modified":15},"NCT06034002","A Study to Evaluate INCA033989 Administered as a Monotherapy or in Combination With Ruxolitinib in Participants With Myeloproliferative Neoplasms",[12],"Phase 1","RECRUITING","2026-08-26T02:18:51.009190Z","2026-05-05T02:43:28.650417Z",{"nct_id":17,"title":18,"phases":19,"status":13,"updated_at":20,"content_modified":21},"NCT07008118","A Study to Evaluate INCA035784 in Participants With Myeloproliferative Neoplasms",[12],"2026-08-26T02:18:09.641312Z","2026-05-05T02:43:27.965447Z",{"nct_id":23,"title":24,"phases":25,"status":13,"updated_at":26,"content_modified":27},"NCT06150157","A Study of JNJ-88549968 for the Treatment of Calreticulin (CALR)-Mutated Myeloproliferative Neoplasms",[12],"2026-08-26T02:16:23.080181Z","2026-04-29T02:57:57.158454Z",{"nct_id":29,"title":30,"phases":31,"status":13,"updated_at":32,"content_modified":33},"NCT05025488","Mutant CALR-peptide Based Vaccine in Patients With Mutated CALR Myeloproliferative Neoplasm",[12],"2026-08-26T02:15:23.202838Z","2026-05-05T02:43:29.683710Z"]